Certified by Founder Lodge
Pivotal bioVenture Partners
United States - SAN FRANCISCO, California
INVESTOR
1 Disclosed Funding Rounds $50,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pivotal bioVenture Partners (U.S.), an affiliate of Pivotal Life Sciences
We back the brightest minds in life sciences.
Our seasoned investment team brings over 50 years combined biotec
| Company | Date | Round | Raised |
|---|---|---|---|
Evommune |
April, 27 ,2023 | Series B | $50,000,000 |
Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
Mosanna Therapeutics |
June, 10 ,2025 | Series A | $80,000,000 |
Evommune
Avalyn Pharma Inc.
Mosanna Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)